Suchergebnis | Hamburg Open Science

Facetten

36 Einträge gefunden

Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
2012 - Forschungsinformationssystem des UKE - frei zugänglich
Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type-3 NF1 deletions.
2012 - Forschungsinformationssystem des UKE
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1.
2012 - Forschungsinformationssystem des UKE - frei zugänglich
Internal tumor burden in neurofibromatosis Type I patients with large NF1 deletions.
2012 - Forschungsinformationssystem des UKE
Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.
2012 - Forschungsinformationssystem des UKE
Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions.
2012 - Forschungsinformationssystem des UKE
Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/-) stem cells.
2012 - Forschungsinformationssystem des UKE
Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports.
2011 - Forschungsinformationssystem des UKE - frei zugänglich
Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.
2011 - Forschungsinformationssystem des UKE
Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation.
2011 - Forschungsinformationssystem des UKE
Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors.
2011 - Forschungsinformationssystem des UKE - frei zugänglich
Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits.
2011 - Forschungsinformationssystem des UKE
Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions.
2010 - Forschungsinformationssystem des UKE
Extended runs of homozygosity at 17q11.2: an association with type-2 NF1 deletions?
2010 - Forschungsinformationssystem des UKE
A novel third type of recurrent NF1 microdeletion mediated by nonallelic homologous recombination between LRRC37B-containing low-copy repeats in 17q11.2.
2010 - Forschungsinformationssystem des UKE
Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletions.
2010 - Forschungsinformationssystem des UKE
Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model.
2010 - Forschungsinformationssystem des UKE
Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.
2010 - Forschungsinformationssystem des UKE
Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.
2010 - Forschungsinformationssystem des UKE
Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes.
2010 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.

Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type-3 NF1 deletions.

Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1.

Internal tumor burden in neurofibromatosis Type I patients with large NF1 deletions.

Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.

Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions.

Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/-) stem cells.

Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports.

Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.

Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation.

Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors.

Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits.

Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions.

Extended runs of homozygosity at 17q11.2: an association with type-2 NF1 deletions?

A novel third type of recurrent NF1 microdeletion mediated by nonallelic homologous recombination between LRRC37B-containing low-copy repeats in 17q11.2.

Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletions.

Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model.

Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.

Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.

Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes.